| |
| |
|
| Insider
Information: |
Massarany Hany |
| Relationship: |
Director |
| City: |
Tucson |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,084,072 |
|
|
Indirect Shares
|
558,432 |
|
|
| Direct
Value |
$18,678,351 |
|
|
|
Indirect Value
|
$12,613,364 |
|
|
| Total
Shares |
1,642,504 |
|
|
| Total
Value |
$31,291,715 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -56.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ventana Medical Systems Inc |
VMSI |
Chief Operating Officer |
2008-02-19 |
0 |
2004-04-21 |
0 |
Premium* |
|
|
Genmark Diagnostics, Inc. |
GNMK |
President and CEO, Dir... |
2019-11-25 |
776,045 |
2019-11-25 |
524,568 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2023-08-03 |
283,767 |
2023-08-03 |
30,864 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director |
2024-01-23 |
24,260 |
2024-01-23 |
3,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
109 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMK |
Genmark Diagnostics, Inc. |
President and CEOOfficer |
• – – |
2011-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
261,249 |
|
- |
|
| VMSI |
Ventana Medical Systems I... |
Chief Operating Officer |
• – – |
2007-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
27,489 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• – – |
2012-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
141,207 |
402,456 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
81,457 |
508,913 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
27,439 |
219,129 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2015-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
143,245 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
57,057 |
189,502 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2016-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,466 |
80,205 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2016-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
250,231 |
308,768 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2017-01-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
69,983 |
350,367 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
191,054 |
405,878 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2018-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
365,000 |
722,190 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2019-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,229 |
707,228 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
217,500 |
909,562 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • – |
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,949 |
75,949 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • – |
2024-01-23 |
4 |
B |
$0.00 |
$0 |
D/D |
16,666 |
24,260 |
2.31 |
% |
|
| BDSX |
Biodesix Inc |
|
• • – |
2022-11-21 |
4 |
B |
$1.15 |
$149,999 |
D/D |
130,434 |
137,934 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
|
• • – |
2023-08-03 |
4 |
A |
$1.62 |
$50,000 |
I/I |
30,864 |
30,864 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • – |
2022-01-31 |
4 |
B |
$3.30 |
$66,000 |
I/I |
20,000 |
30,000 |
2.1 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2018-02-26 |
4 |
S |
$4.17 |
$72,141 |
D/D |
(17,300) |
704,890 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2012-06-26 |
4 |
B |
$4.20 |
$105,000 |
D/D |
25,000 |
427,456 |
2.81 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2018-02-20 |
4 |
S |
$4.37 |
$28,772 |
D/D |
(6,584) |
357,190 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2017-11-20 |
4 |
S |
$4.74 |
$39,114 |
D/D |
(8,252) |
362,957 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2018-11-20 |
4 |
S |
$4.84 |
$38,947 |
D/D |
(8,047) |
672,883 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
President and CEO |
• • – |
2018-11-05 |
4 |
S |
$4.85 |
$7,571 |
D/D |
(1,561) |
680,930 |
0 |
- |
|
109 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
